Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2013 (2013), Article ID 142358, 5 pages
http://dx.doi.org/10.1155/2013/142358
Research Article

Significant Association between Serum Interleukin-6 and Helicobacter pylori Antibody Levels among H. pylori-Positive Japanese Adults

1Department of Preventive Medicine, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, Japan
2Department of Hematology and Oncology, Higashi Nagoya National Hospital, National Hospital Organization, Nagoya 465-8620, Japan
3Department of Pathophysiological Laboratory Sciences, Nagoya University Graduate School of Medicine, Nagoya 461-8673, Japan
4Department of Healthcare Administration, Nagoya University Graduate School of Medicine, Nagoya 466-8550, Japan

Received 10 October 2013; Accepted 30 November 2013

Academic Editor: Leif P. Andersen

Copyright © 2013 Hiroko Nakagawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Hirano, S. Akira, T. Taga, and T. Kishimoto, “Biological and clinical aspects of interleukin 6,” Immunology Today, vol. 11, no. 12, pp. 443–449, 1990. View at Google Scholar · View at Scopus
  2. Y. Horii, A. Muraguchi, M. Iwano et al., “Involvement of IL-6 in mesangial proliferative glomerulonephritis,” Journal of Immunology, vol. 143, no. 12, pp. 3949–3955, 1989. View at Google Scholar · View at Scopus
  3. G. K. Hansson, “Inflammation, atherosclerosis, and coronary artery disease,” The New England Journal of Medicine, vol. 352, no. 16, pp. 1685–1695, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. L. Mehta, T. G. P. Saldeen, and K. Rand, “Interactive role of infection, inflammation and traditional risk factors in atherosclerosis and coronary artery disease,” Journal of the American College of Cardiology, vol. 31, no. 6, pp. 1217–1225, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Ikonomidis, K. Stamatelopoulos, J. Lekakis, G. D. Vamvakou, and D. T. Kremastinos, “Inflammatory and non-invasive vascular markers: the multimarker approach for risk stratification in coronary artery disease,” Atherosclerosis, vol. 199, no. 1, pp. 3–11, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Zakynthinos and N. Pappa, “Inflammatory biomarkers in coronary artery disease,” Journal of Cardiology, vol. 53, no. 3, pp. 317–333, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. B. C. Berk, W. S. Weintraub, and R. W. Alexander, “Elevation of C-reactive protein in “active” coronary artery disease,” American Journal of Cardiology, vol. 65, no. 3, pp. 168–172, 1990. View at Publisher · View at Google Scholar · View at Scopus
  8. S. G. Thompson, J. Kienast, S. D. M. Pyke et al., “Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris,” The New England Journal of Medicine, vol. 332, no. 10, pp. 635–641, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. D. I. Buckley, R. Fu, M. Freeman, K. Rogers, and M. Helfand, “C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. preventive services task force,” Annals of Internal Medicine, vol. 151, no. 7, pp. 483–495, 2009. View at Google Scholar · View at Scopus
  10. R. F. Mortensen, “C-reactive protein, inflammation, and innate immunity,” Immunologic Research, vol. 24, no. 2, pp. 163–176, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. W. Koenig, N. Khuseyinova, J. Baumert et al., “Increased concentrations of C-reactive protein and IL-6 but not IL-18 are independently associated with incident coronary events in middle-aged men and women: results from the MONICA/KORA Augsburg case-cohort study, 1984–2002,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 12, pp. 2745–2751, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. M. B. Lobbes, E. Lutgens, S. Heeneman et al., “Is there more than C-reactive protein and fibrinogen? The prognostic value of soluble CD40 ligand, interleukin-6 and oxidized low-density lipoprotein with respect to coronary and cerebral vascular disease,” Atherosclerosis, vol. 187, no. 1, pp. 18–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. J. Danesh, S. Kaptoge, A. G. Mann et al., “Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review,” PLoS Medicine, vol. 5, no. 4, article e78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. D. Su, Z. Li, X. Li et al., “Association between serum interleukin-6 concentration and mortality in patients with coronary artery disease,” Mediators of Inflammation, vol. 2013, Article ID 726178, 7 pages, 2013. View at Publisher · View at Google Scholar
  15. E. Lindmark, E. Diderholm, L. Wallentin, and A. Siegbahn, “Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvasive strategy,” The Journal of the American Medical Association, vol. 286, no. 17, pp. 2107–2113, 2001. View at Google Scholar · View at Scopus
  16. M. A. Mendall, P. M. Goggin, N. Molineaux et al., “Relation of Helicobacter pylori infection and coronary heart disease,” British Heart Journal, vol. 71, no. 5, pp. 437–439, 1994. View at Google Scholar · View at Scopus
  17. K. Kinjo, H. Sato, H. Sato et al., “Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction,” Circulation Journal, vol. 66, no. 9, pp. 805–810, 2002. View at Google Scholar · View at Scopus
  18. H. Osawa, M. Kawakami, M. Fujii et al., “Helicobacter pylori infection and coronary heart disease in Japanese patients,” Cardiology, vol. 95, no. 1, pp. 14–19, 2001. View at Publisher · View at Google Scholar · View at Scopus
  19. V. Pasceri, G. Cammarota, G. Patti et al., “Association of virulent Helicobacter pylori strains with ischemic heart disease,” Circulation, vol. 97, no. 17, pp. 1675–1679, 1998. View at Google Scholar · View at Scopus
  20. J. Danesh, L. Youngman, S. Clark, S. Parish, R. Peto, and R. Collins, “Helicobacter pylori infection and early onset myocardial infarction: case-control and sibling pairs study,” British Medical Journal, vol. 319, no. 7218, pp. 1157–1162, 1999. View at Google Scholar · View at Scopus
  21. M. Mayr, S. Kiechl, M. A. Mendall, J. Willeit, G. Wick, and Q. Xu, “Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study,” Stroke, vol. 34, no. 3, pp. 610–615, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. F. Franceschi, G. Niccoli, G. Ferrante et al., “CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases,” Atherosclerosis, vol. 202, no. 2, pp. 535–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. W. Koenig, D. Rothenbacher, A. Hoffmeister et al., “Infection with Helicobacter pylori is not a major independent risk factor for stable coronary heart disease: lack of a role of cytotoxin-associated protein A-positive strains and absence of a systemic inflammatory response,” Circulation, vol. 100, no. 23, pp. 2326–2331, 1999. View at Google Scholar · View at Scopus
  24. A. F. Stone, P. Risley, H. S. Markus et al., “Ischaemic heart disease and Cag a strains of Helicobacter pylori in the Caerphilly heart disease study,” Heart, vol. 86, no. 5, pp. 506–509, 2001. View at Google Scholar · View at Scopus
  25. R. Pellicano, P. P. Parravicini, R. Bigi et al., “Infection by Helicobacter pylori and acute myocardial infarction. Do cytotoxic strains make a difference?” New Microbiologica, vol. 25, no. 3, pp. 315–321, 2002. View at Google Scholar · View at Scopus
  26. P. Whincup, J. Danesh, M. Walker et al., “Prospective study of potentially virulent strains of Helicobacter pylori and coronary heart disease in middle-aged men,” Circulation, vol. 101, no. 14, pp. 1647–1652, 2000. View at Google Scholar · View at Scopus
  27. L. J. Murray, K. B. Bamford, F. Kee et al., “Infection with virulent strains of Helicobacter pylori is not associated with ischaemic heart disease: evidence from a population-based case-control study of myocardial infarction,” Atherosclerosis, vol. 149, no. 2, pp. 379–385, 2000. View at Publisher · View at Google Scholar · View at Scopus
  28. J. S. Yudkin, C. D. A. Stehouwer, J. J. Emeis, and S. W. Coppack, “C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 4, pp. 972–978, 1999. View at Google Scholar · View at Scopus
  29. K. Miki, M. Ichinose, A. Shimizu et al., “Serum pepsinogens as a screening test of extensive chronic gastritis,” Gastroenterologia Japonica, vol. 22, no. 2, pp. 133–141, 1987. View at Google Scholar · View at Scopus
  30. G. N. Stemmermann, I. M. Samloff, A. M. Y. Nomura, and L. K. Heilbrun, “Serum pepsinogens I and II and stomach cancer,” Clinica Chimica Acta, vol. 163, no. 2, pp. 191–198, 1987. View at Google Scholar · View at Scopus
  31. A. Kodoi, M. Yoshihara, K. Sumii, K. Haruma, and G. Kajiyama, “Serum pepsinogen in screening for gastric cancer,” Journal of Gastroenterology, vol. 30, no. 4, pp. 452–460, 1995. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Miki and Y. Urita, “Using serum pepsinogens wisely in a clinical practice,” Journal of Digestive Diseases, vol. 8, no. 1, pp. 8–14, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Mizuno, M. Kobayashi, S. Tomita et al., “Validation of the pepsinogen test method for gastric cancer screening using a follow-up study,” Gastric Cancer, vol. 12, no. 3, pp. 158–163, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Amedei, F. Munari, C. D. Bella et al., “Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma,” Internal and Emergency Medicine, 2012. View at Publisher · View at Google Scholar
  35. M. Benagiano, F. Munari, A. Ciervo et al., “Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 4, pp. 1222–1227, 2012. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Manolakis, A. N. Kapsoritakis, and S. P. Potamianos, “A review of the postulated mechanisms concerning the association of Helicobacter pylori with ischemic heart disease,” Helicobacter, vol. 12, no. 4, pp. 287–297, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. A. M. Alkout, E. J. Ramsay, D. A. C. Mackenzie et al., “Quantitative assessment of IgG antibodies to Helicobacter pylori and outcome of ischaemic heart disease,” FEMS Immunology and Medical Microbiology, vol. 29, no. 4, pp. 271–274, 2000. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Novák, Z. Szekanecz, J. Sebesi et al., “Elevated levels of anti-Helicobacter pylori antibodies in Henoch-Schönlein purpura,” Autoimmunity, vol. 36, no. 5, pp. 307–311, 2003. View at Publisher · View at Google Scholar · View at Scopus
  39. I. Yamamoto, Y. Fukuda, T. Mizuta, M. Fukada, T. Nishigami, and T. Shimoyama, “Serum anti-Helicobacter pylori antibodies and gastritis,” Journal of Clinical Gastroenterology, vol. 21, no. 1, supplment 1, pp. S164–S168, 1995. View at Google Scholar · View at Scopus
  40. J. Kreuning, J. Lindeman, I. Biemond, and C. B. Lamer, “Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity gastritis in asymptomatic subjects,” Journal of Clinical Pathology, vol. 47, no. 3, pp. 227–231, 1994. View at Google Scholar · View at Scopus